i
STD testing among pregnant women in the United States, 2011-2015
-
February 2020
-
-
Source: Sex Health. 17(1):1-8
[PDF-93.95 KB]
Details:
-
Alternative Title:Sex Health
-
Personal Author:
-
Description:Introduction:
Sexually transmitted diseases (STDs) are increasing in the United States. Pregnant women and infants are susceptible to serious STD-related sequelae; however, some STDs can be cured during pregnancy with appropriate, timely screening.
Methods:
We used data from the 2011–2015 National Survey of Family Growth to examine STD testing (in the past 12 months) among women who were pregnant in the past 12 months (n=1,155). In bivariate and multivariable analyses, we examined associations between demographics, health care access and two outcome variables – receipt of chlamydia test and receipt of other STD test.
Results:
Among women who were pregnant in the past 12 months, 48% reported receiving a chlamydia test and 54% reported that they received a STD test other than chlamydia in the past 12 months. In adjusted analyses, non-Hispanic black women were more likely to receive a chlamydia test (aOR=2.82, 1.86–4.26) and other STD test (aOR=2.43, 1.58–3.74) than non-Hispanic white women. Women living in a metropolitan statistical area but not the principal city were less likely to report chlamydia (aOR=0.62, 0.44–0.86) and other STD testing (aOR=0.57, 0.40–0.81) than women living in a principal city. Women born outside of the U.S. were significantly less likely to have received a chlamydia test (aOR=0.35, 0.19–0.64) or other STD test (aOR=0.34, 0.20–0.58) while those who had received prenatal care were more likely to receive a chlamydia test (aOR=2.10, 1.35–3.28) or other STD test (aOR=2.32, 1.54–3.49).
Conclusions:
Our findings suggest that interventions are needed to increase adherence to recommended STD screenings during pregnancy.
-
Subjects:
-
Source:
-
Pubmed ID:31677644
-
Pubmed Central ID:PMC7078010
-
Document Type:
-
Funding:
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type:
